Insulin resistance activates signaling pathways, such as P38 and extracellular signal-regulated kinase (ERK) pathways, to increase the expression of TGF-β, while increased oxidative stress cooperates with the activated polyol pathway to stimulate the protein kinase C (PKC) pathway [14, 31]. The gene discussed is PRRT2; the disease is Insulin resistance.